Deciding how to treat your breast cancer can be a very difficult and personal decision. Dr. Cindy Matsen, breast surgeon at Huntsman Cancer Institute, says it’s easy for women who begin initial ...

If you've recently been diagnosed with breast cancer, you'll be faced with some decisions about the care you'll receive. Depending on the type, location, stage and other aspects of your cancer, you ...

Many women who are diagnosed with breast cancer face the difficult decision of whether to have a lumpectomy with radiation or a mastectomy with reconstruction. With the availability of study results ...

A lumpectomy is a surgical procedure that removes cancer from the breast. Unlike a mastectomy — which removes the entire breast — a lumpectomy removes just the area of the breast where there is cancer ...

A new U.S. study examining survival rates for women with early stage breast cancer found that surgery such as lumpectomy that preserves the rest of the breast may offer survival odds as good as, or ...

Lumpectomy is the gold standard for breast cancer surgery, says Kirstyn E. Brownson, MD, a surgical breast oncologist at Huntsman Cancer Institute. We asked Dr. Brownson to explain what a lumpectomy ...

For those with localized breast cancer, surgical options may include either lumpectomy or mastectomy, and patients have free rein about which to choose. Star Mackenzie Burruto had just gotten off the ...

WEDNESDAY, March 5, 2025 (HealthDay News) -- Opting for a lumpectomy during breast cancer treatment can protect a woman’s future sex life, a new study suggests. Breast-conserving therapy (BCT) is ...

(02-06) 10:47 PST SAN FRANCISCO-- For decades, clinical trials and other studies have shown that women with early-stage breast cancer have the same survival odds whether they choose to have a surgery ...

A 31-year-old woman underwent a right lumpectomy and sentinel lymph node sampling for a breast mass. Pathology showed a 21 x 11 mm medullary carcinoma of the breast, with clear margins; lymph nodes ...

Molecular and genomic predictors of response to single-agent doxorubicin (ADR) versus single-agent docetaxel (DOC) in primary breast cancer (PBC). Background: In women 70 years of age or older with ...